公司简介

4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy products using our proprietary.

产品/服务

• 科技服务
• DTC基因检测

Gene Therapy

AAV Vectors

diseases of the retina

liver and CNS。

融资信息

融资轮次	融资日期	投资方	融资额度
Venture	2015-08	未披露	$7M
C轮	2020-06	Viking Global Investors, Amzak Health、Casdin Capital、Cystic Fibrosis Foundation、Longevity Vision Fund、MiraeAsset、Octagon Investments, QUAD Investment Management, Arrowmark Partners、Berkeley Catalyst Fund、BVF Partners L.P.、Pappas Capital & Chiesi Ventures、Perceptive Advisors、Pfizer Ventures和Ridgeback Capital Investments	7500万美元

关联公司